Celldex Therapeutics (CLDX) Revenue (2010 - 2026)
Celldex Therapeutics (CLDX) posted quarterly Revenue of $15000.0 for Q1 2026, down 97.84% year-over-year from $695000.0 in Q1 2025, and down 87.6% quarter-over-quarter from $121000.0 in Q4 2025.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Revenue (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Revenue history runs 17 years deep, the most recent figure standing at $15000.0 for Q1 2026.
- In Q1 2026, Revenue fell 97.84% year-over-year to $15000.0; the TTM figure through Mar 2026 stood at $866000.0 (down 88.54% YoY), while the FY2025 annual figure was $1.5 million, down 77.99% from the prior year.
- Revenue for Q1 2026 stood at $15000.0, down from $121000.0 in the prior quarter.
- The five-year high for Revenue was $4.1 million in Q4 2023, with the low at $15000.0 in Q1 2026.
- The 5-year median for Revenue is $712500.0 (2025), against an average of $1.1 million.
- The sharpest annual moves came in 2024 and 2026: Revenue surged 832.09% in 2024, then slumped 97.84% in 2026.
- Celldex Therapeutics' Revenue stood at $1.6 million in 2022, then surged by 156.11% to $4.1 million in 2023, then slumped by 71.56% to $1.2 million in 2024, then slumped by 89.7% to $121000.0 in 2025, then slumped by 87.6% to $15000.0 in 2026.
- Business Quant data shows CLDX's Revenue at $15000.0 in Q1 2026, $121000.0 in Q4 2025, and $730000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Celldex Therapeutics | 3.10 Bn | 3.10 Bn | -2.57 Mn | 22,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | 121,000.00 |
| Jun 30, 2025 | 730,000.00 |
| Mar 31, 2025 | 695,000.00 |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 3.19 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 4.13 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 268,000.00 |
| Mar 31, 2023 | 967,000.00 |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 407,000.00 |
| Jun 30, 2022 | 163,000.00 |
| Mar 31, 2022 | 174,000.00 |
| Dec 31, 2021 | 334,000.00 |
| Sep 30, 2021 | 153,000.00 |
| Jun 30, 2021 | 3.48 Mn |